Johnson & Johnson: Number of Employees 2010-2024 | JNJ
Interactive chart of Johnson & Johnson (JNJ) annual worldwide employee count from 2010 to 2024.
- Johnson & Johnson total number of employees in 2023 was 131,900, a 15.34% decline from 2022.
- Johnson & Johnson total number of employees in 2022 was 155,800, a 9.95% increase from 2021.
- Johnson & Johnson total number of employees in 2021 was 141,700, a 5.35% increase from 2020.
- Johnson & Johnson total number of employees in 2020 was 134,500, a 1.74% increase from 2019.
| Johnson & Johnson Annual Employee Count |
| 2023 |
131,900 |
| 2022 |
155,800 |
| 2021 |
141,700 |
| 2020 |
134,500 |
| 2019 |
132,200 |
| 2018 |
135,100 |
| 2017 |
134,000 |
| 2016 |
126,400 |
| 2015 |
127,100 |
| 2014 |
126,500 |
| 2013 |
128,100 |
| 2012 |
127,600 |
| 2011 |
117,900 |
| 2010 |
114,000 |
| 2009 |
115,500 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$357.584B |
$85.159B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
